Given the characteristics of mildly elevated cerebrospinal fluid protein levels, lymph node histopathology, Myc and BCL-6 rearrangement detected by standard cytogenetics, and weak Bcl-2 positivity, the disease is consistent with a diagnosis of high-grade B-cell lymphoma. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.